Providing a diverse range of perspectives from bullish to bearish, 14 analysts have published ratings on Sage Therapeutics (NASDAQ:SAGE) in the last three months.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 3 | 10 | 0 | 1 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 0 | 2 | 6 | 0 | 0 |
2M Ago | 0 | 1 | 2 | 0 | 0 |
3M Ago | 0 | 0 | 1 | 0 | 1 |
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $16.64, with a high estimate of $25.00 and a low estimate of $8.00. This current average has decreased by 18.83% from the previous average price target of $20.50.
![bigjpg](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240730/0-d08426157baf70b70f181f22566b8bde-0-442c3717618a2c414552bd9085c2e7e8.webp/bigjpg)
Deciphering Analyst Ratings: An In-Depth Analysis
The analysis of recent analyst actions sheds...
Login or create a forever free account to read this news
Sign up/Log in